Even so, the findings provide clarity for patients and clinicians navigating a rapidly evolving area of care
Pausing semaglutide is not recommended as a tolerance-reset strategy
In response to GLP-1 receptor agonists, the increased level of intracellular cAMP inhibits the proliferative cascade and further cell invasion [71,72,73]
Promoting lifestyle changes, education and counseling, in addition to traditional medicine, the program focuses on diabetes and pre-diabetes but also addresses related illnesses such as obesity, chronic kidney disease, sleep apnea and liver disease
The proposed litigation involved claims that GLP-1 medications caused non-arteritic anterior ischemic optic neuropathy and that manufacturers failed to properly warn about this alleged risk